A subset of human helper memory T cells is known to adhere to E-selectin expressed on cytokine-activated endothelial cells. However, sialyl Lex antigen, the carbohydrate ligand for E-selectin, has been hardly detectable on these cells, at least when typical anti-sialyl Le" antibodies were used for detection. One of the MoAbs (2F3, IgM), which we raised against a chemically synthesized sialyl Le" glycolipid preparation, is found to react selectively to CD4' CD45RObnght+CD45RA-helper memory T cells among peripheral lymphocytes in healthy individuals. The specificity of the antibody is in clear contrast to that of the hitherto reported typical anti-sialyl Le" antibodies FH-6 and SNH-3. These classical anti-sialyl Le" antibodies were known to react to a subset of natural killer (NK) cells, but were not reactive with any particular subset of resting peripheral T or B cells of healthy individuals if the cells were not activated. On the other hand, the newly generated 2F3 antibody specifically reacted to helper memory T cells, and did not react to NK cells, B cells, or any T cells other than helper memory T cells. When tested against the sialyl Lexactive glycolipid antigen, the reactivity of 2F3 was not significantly different from that of the classical anti-sialyl Le" antibodies. But when tested against oligosaccharides prepared from cellular glycoproteins, 2F3 detected a distinct IALYL Le" antigen is known to serve as a ligand for the S cell adhesion molecule, E-selectin.'4 The antigen is strongly expressed on granulocytes and monocytes and is implicated in the acute inflammation process. Some lymphocytes are also known to express the antigen and are considered to have an ability to adhere to endothelial E-selectin molecule^.^,^ In previous studies, we showed that only a subset of natural killer (NK) cells expressed the antigen among the peripheral lymphocytes of healthy individuals, at least when the well-characterized anti-sialyl Le" antibodies, SNH-3 or FH-6, were used for detection. Resting T and B cells do not express the antigen until they are activated by antigenic or other appropriate tim mu la ti on.',^ On the other hand, it has been reported that a certain subset of human helper memory T cells adheres to endothelial cells via E-sele~tin.~-'~ We first thought in light of our previous that these helper memory T cells are probably activated T cells that express the classical sialyl Le" antigen. However, in our preliminary experiments using the SNH-3 and FH-6 antibodies, it was found that the vast majority of sialyl Le"-positive T cells in patients having activated T cells in peripheral blood were CDS+ cells, and Le"-positive CD4+ T cells were only occasionally encountered when SNH-3 and FH-6 were used for flow cytometric analysis. Other investigators also postulated that the other antisialyl Le" antibody CSLEX-1 could detect only a minute population of T cells that remained un~haracterized.'~ This prompted us to study further the nature of the E-selectin carbohydrate ligand at the surface of helper memory T cells.
A subset of human helper memory T cells is known to adhere to E-selectin expressed on cytokine-activated endothelial cells. However, sialyl Lex antigen, the carbohydrate ligand for E-selectin, has been hardly detectable on these cells, at least when typical anti-sialyl Le" antibodies were used for detection. One of the MoAbs (2F3, IgM), which we raised against a chemically synthesized sialyl Le" glycolipid preparation, is found to react selectively to CD4' CD45RObnght+CD45RA-helper memory T cells among peripheral lymphocytes in healthy individuals. The specificity of the antibody is in clear contrast to that of the hitherto reported typical anti-sialyl Le" antibodies FH-6 and SNH-3. These classical anti-sialyl Le" antibodies were known to react to a subset of natural killer (NK) cells, but were not reactive with any particular subset of resting peripheral T or B cells of healthy individuals if the cells were not activated. On the other hand, the newly generated 2F3 antibody specifically reacted to helper memory T cells, and did not react to NK cells, B cells, or any T cells other than helper memory T cells. When tested against the sialyl Lexactive glycolipid antigen, the reactivity of 2F3 was not significantly different from that of the classical anti-sialyl Le" antibodies. But when tested against oligosaccharides prepared from cellular glycoproteins, 2F3 detected a distinct IALYL Le" antigen is known to serve as a ligand for the S cell adhesion molecule, E-selectin. '4 The antigen is strongly expressed on granulocytes and monocytes and is implicated in the acute inflammation process. Some lymphocytes are also known to express the antigen and are considered to have an ability to adhere to endothelial E-selectin molecule^.^,^ In previous studies, we showed that only a subset of natural killer (NK) cells expressed the antigen among the peripheral lymphocytes of healthy individuals, at least when the well-characterized anti-sialyl Le" antibodies, SNH-3 or FH-6, were used for detection. Resting T and B cells do not express the antigen until they are activated by antigenic or other appropriate tim mu la ti on.',^ On the other hand, it has been reported that a certain subset of human helper memory T cells adheres to endothelial cells via E-sele~tin.~-'~ We first thought in light of our previous that these helper memory T cells are probably activated T cells that express the classical sialyl Le" antigen. However, in our preliminary experiments using the SNH-3 and FH-6 antibodies, it was found that the vast majority of sialyl Le"-positive T cells in patients having activated T cells in peripheral blood were CDS+ cells, and Le"-positive CD4+ T cells were only occasionally encountered when SNH-3 and FH-6 were used for flow cytometric analysis. Other investigators also postulated that the other antisialyl Le" antibody CSLEX-1 could detect only a minute population of T cells that remained un~haracterized.'~ This prompted us to study further the nature of the E-selectin carbohydrate ligand at the surface of helper memory T cells.
It is well known that the Lex, or SSEA-1 antigenic determiset of 0-linked oligosaccharides, which were not reactive to the classical anti-sialyl Le" antibodies. Our results suggest that various molecular species of sialyl LeX antigens are present on carbohydrate side chains of cellular glycoproteins, and that helper memory T cells express a distinct type of sialyl Le" antigen that is defined by 2F3 but is not efficiently detected by other typical anti-sialyl Le" antibodies. Among cultured lymphocytic leukemia cells, the adult T-cell leukemia (ATL) cells preferentially expressed the 2F3-defined antigen, and acute lymphocytic leukemia cells rarely expressed the antigen. The cultured ATL cells expressing the 2F3-defined antigen showed a clear E-selectin-dependent adhesion to cytokin-activated endothelial cells, and the 2F3-defined sialyl LeX antigen served as a ligand for E-selectin as ascertained by the clear inhibition of adhesion with the 2F3 antibody. The 2F3-defined sialyl Le" antigen tended to be expressed on the ATL cells from the patients with dermal infiltration of leukemic cells more strongly than on the ATL cells from the patients without skin involvement, suggesting that the cell adhesion mediated by the 2F3-defined sialyl Le" antigen plays a role in the skin infiltration process of ATL cells. 
MATERIALS AND METHODS
Generation of MoAbs against chemically synthesized sialyl Le' glycolipid. The pure synthetic sialyl Le" glycolipid used for the generation of anti-sialyl Le" MoAbs had the structure, NeuAccu2 + 3Gal@ I + 4(Fuca I --* 3)
Hybridoma cells that secrete MoAbs directed to chemically synthesized sialyl Le" antigen were generated according to the method described by Kohler and Milstein,I6 and subsequently modified for anti-carbohydrate antibodies. I7 Briefly, the synthetic glycolipid was incorporated to MPL-lipid liposomes (RIBI, Hamilton, MT) and used for repeated intraperitoneal immunizations of BALB/c mice on day 0 (7 pg), day 7 ( 1 5 pg), day 14 (23 pg), and day 28 (23 pg). Three days after the final immunization the spleen cells were harvested and fused with mouse myeloma P3/X63-Ag8Ul (P3UI). The synthetic glycolipid was used as the antigen in the solid-phase enzymoimmunoassay of culture supernatants of hybridomas for the cloning procedures. Ten positive hybridoma clones, 2F9, 3A7, 3A8,3C12,4Bl, 4G10,2F3,3D1, 3D5, and 4D12 (all IgM except 3D1, which was IgG,,) were obtained. Because only the 2F3 antibody showed distinct characteristics in the reactivity toward lymphocytes, this clone was used for studies described in this report, and other newly prepared anti-sialyl Le" antibodies are not further described here.
Cells and MoAbs for flow cytometric analysis. MoAbs SNH-3
(specific to sialyl Le", IgM) and FH-6 (specific to sialyl Le"-i, IgM) were supplied by Dr Sen-itiroh Hakomori (Biomembrane Institute, Seattle, WA) and were purified from ascitic fluids as described previously,2. 7.8.18 Among the antibodies used for the cell surface marker analysis, Leu 4 (CD3) for T cells, Leu 12 (CD19), for B cells, and Leu 1 1 (CD16) for NK cells were obtained from Becton Dickinson Immunocytometry Systems (Mountain View, CA). The anti-CD45RO antibody, UCHLl (murine IgG,,) was obtained from Dako A/S (Glostrup, Denmark). The anti-CD45RA antibody, 2H4 (murine IgGJ, was supplied from the Coulter Immunology Division (Hialeah, FL).
Peripheral blood samples were obtained from healthy donors and patients with lymphoid malignancies including adult T-cell leukemia (ATL) being treated at Kyoto University Hospital and Kagoshima Municipal Hospital. Lymphocytes were isolated from Ficoll/ Hypaque (Pharmacia, Uppsala, Sweden) by standard methods."
Cultured human lymphoid cell lines, PI 2/Ichikawa and MOLT-15 were supplied by Dr Jun Minowada, Fujisaki Cell Center, Hayashibara Biology Research Institute, Okayama Japan. HPB-ALL, MOLT-3, and Jurkat were obtained from the First Division of Department of Internal Medicine, Kyoto University. HUT102 was maintained in the Laboratory of Chemotherapy, Aichi Cancer Research Institute, and was supplied by Dr Ryuzo Ueda. ATL-2 and ED-405 I5 were established in the Chest Disease Research Institute, Kyoto University. The ED-405 15 cells are a cell line derived from a patient with ATL, and require the supplementation of interleukin-2 (IL-2) in the culture medium for growth. HIL3, another IL-2-dependent cell line, was a gift from Dr Tasuku Honjo, Department of Medical Chemistry, Kyoto University. MT-1 and MT-2 were gifts from Dr Isao Miyoshi, Kouchi Medical University. These cells were cultured in RPMI 1640 medium supplemented with 10% fetal calf ED-405 I5 and HIL3 were maintained in the same medium supplemented by 50 U/mL of recombinant human IL-2 (Genzyme, Cambridge, MA). Flow cytometric analysis of lymphocytes was performed using FACScan (Becton Dickinson Immunocytometry Systems). The indirect immunofluorescence method was applied for staining of lymphocytes with the antibodies 2F3, SNH-3, and FH-6, using a fluorescein isothiocyanate (F1TC)-labeled rabbit anti-murine IgM (p-chain-specific) antibody as the second antibody (Cappel Inc, Malvern, PA). Two-color or three-color analysis using antibodies to other known lymphocyte markers was routinely performed for the characterization of T cells reactive to these antibodies. FITC and phycoerythrin (PE) were used for FLI and FL2 in two-color analysis, and RED61 3 (streptavidin-RED6 13; Becton Dickinson Immunocytometry Systems) was used for FL3 in three-color analysis.
Enzyme-linked immunosorbent assay (ELISA) was performed using various glycolipid antigens that were immobilized at the bottom of 96-well culture plates by a standard method described previously.22 Peroxidase-conjugated goat anti-mouse IgM (p-chain specific) were obtained from Cappel Inc. Thin-layer chromatography (TLC)-immunostaining was performed using a Baker HPTLC plate (Baker, Phillipsburg, NJ) and 1251-protein A (Du Pont, Boston, MA) as described p r e v i~u s l y . '~~~~ The solvent system for TLC was chloroform/methanol/0.5% CaCI, in H,O (55:40: IO, vol/vol/vol).
Cell surface 0-linked oligosaccharides were prepared from cancer tissues (mainly colon cancers) by @-elimination, and conjugated with anilino-cholesterol. Briefly, tissues were treated three times with chloroform/methanol solvents (2: 1, I: 1, and 1 :2, vol/ vol) successively, and the glycoproteins were extracted from the residue with distilled water. Extracted glycoproteins were treated with 0.2N NaOH for 2 hours at room temperature to obtain free oligosaccharides. Oligosaccharides were then linked to anilino-cholesterol by reductive amination. Details of this method will be described el~ewhere.'~ Cell adhesion experiments using human umbilical vein endothelial cells (HUVECs) . HUVECs (2 to 6 passages after isolation; Kurabou CO Ltd, Osaka, Japan) were stimulated with I .O ng/mL of recombinant (r)IL-l@ for 4 hours in flat-bottomed 96-well plate^.*^^"^^ To these plates, '251-labeled cultured leukemia cells (1 X 105/60 pL/well) were added and incubated for 30 minutes at room temperature with rotation using a Double Shaker NR-3 (Taitec Inc, Tokyo, Japan) at the rotation speed gauge setting of 120 rpm. After washing three times, the adherent cells were treated with 1 YO Triton X-100. The lysate was collected using a Skatron supernatant collection system (Skatron A/S, Lier, Norway), and the radioactivity in each well was measured with a y-counter. The number of attached cells was calculated from the specific radioactivity of the labeled cells. The number of cells attached to IL-]&activated HUVECs is taken as loo%, whereas that to HUVECs without IL-I@ stimulation was taken as 0%.
The r I L l @ was obtained from the Central Research Laboratory of Otsuka Pharmaceutical CO, Tokushima Japan, and the recombinant basic fibroblast growth factor used for the in vitro culture of HUVECs was from the Central Research Laboratory of Takeda Pharmaceutical CO, Juso, Japan.
Monoclonal anti-E-selectin, anti-intercellular adhesion molecule (ICAM-I ) and anti-endothelial-leukocyte adhesion molecule (VCAM-1) antibodies (BBA2, BBA4, and BBA6, all murine IgG,) were obtained from British Biotechnology Ltd, Abington, Oxon, United Kingdom. For inhibition experiments, these antibodies were preincubated with HUVECs at 50 pg/mL for 30 minutes at 37°C before the adhesion experiments with leukemia When a mixture of these MoAbs was used for preincubation of HUVECs, the final concentration of each antibody in the preincuMethods for characterization of the anti-sialyl Le' MoAb.
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bation period was adjusted to 50 rg/mL. Monoclonal anti-LFAM (CBL5, IgG,) was obtained from Immunotechs SA (Marseille, France), and this antibody was preincubated with cultured leukemia cells at 50 pg/mL for 30 minutes at room temperature before application to the monolayer of HUVECs. MoAbs 2F3, SNH3, or FH-6 were preincubated with cultured leukemia cells at 25 to 100 pg/mL for 30 minutes at room temperature before application to the monolayer of HUVECs for inhibition of cell adhe~ion.'~,~'
RESULTS

Distribution
Of the antigen recogflized bY the 2F3 antiWhen lymbody among peripheral human lymphocytes.
For phocytes prepared from normal donors were analyzed by flow cytometry with classical anti-sialyl Le" antibodies SNH-3 and FH-6, both antibodies did not stain T or B cells and stained only NK cells (Fig 1) . FH-6 stained NK cells more strongly than SNH-3. These findings are compatible with results previously reported by On the other hand, the 2F3 antibody preferentially detected some of the T lymphocytes and was not reactive with any B or NK cells. The T lymphocytes positively stained with the 2F3 antibody were exclusively CD4+ T cells, and no staining of CD8' T cells was observed (Fig 1) . When lymphocyte preparations prepared from 12 normal donors were analyzed, 10.8% f 4.7% of CD4+ T cells were positively stained by the antibody on average. On the other hand, the staining of T cells with classical anti-sialyl Le" antibodies SNH-3 and FH-6 was negligible; only 1.0% -t 0.8% and 1.8% +-0.8% of CD4+ T cells were stained by SNH-3 and FH-6, respectively.
The result of three-color analysis using 2F3, Leu 3 (anti-CD4), and 2H4 (anti-CD45RA) or UCHLl (anti-CD45RO) indicated that these 2F3+ helper T cells were exclusively CD45RA-CD45RO+ memory T cells and not the CD45RA+CD45RO-naive T cells (Fig 2) . All of the helper T cells stained by 2F3 were CD45RObnph'+ cells, and no significant staining of CD45RO&"+ helper T cells was detected. This was consistently observed with lymphocyte preparations from five different donors.
Characterization of the carbohydrate antigens recognized by the 2F3 antibody. The antibody 2F3 was strongly reactive with the synthetic sialyl Le" antigen as well as SNH-3. The ELISA using the glycolipid antigen, either chemically synthesized sialyl Le" (Fig 3) or the antigen purified from human cancer tissues (data not shown), failed to show any difference between these two antibodies. These results indicate that 2F3, as equally well as SNH-3 and FH-6, recognizes the sialyl Le" haptenic structure that is camed by glycolipids.
On the other hand, when the oligosaccharides derived from a glycoprotein fraction of human cancer tissues were used, a clear difference was observed between these two antibodies. Figure 4 illustrates the TLC-immunostaining pattern of 0-linked oligosaccharides bound to anilino-cholesterol (the neoglycolipids), which indicates that the 2F3 stains multiple oligosaccharide bands, as marked by arrowheads, whereas the antibody SNH-3 stains a completely different set of oligosaccharide bands, as marked with aster- isks. These results indicate that 2F3 recognizes a particular molecular species of the sialyl Le"-like oligosaccharide determinants (2F3defined sialyl Le") camed by the cell surface glycoproteins, which are quite different from those recognized with SNH-3 or FH-6.
Expression ofthe 2F3-defined sialvl Le" antigen among ciilrrired Ieiikemia cells. As reported previously, the classical anti-sialyl Le" antibodies SNH-3 and FH-6 preferentially detect antigens expressed on cultured lymphoid leukemia cells having immature characteristics, such as common acute lymphocytic leukemia (ALL) cells, but less frequently expressed on leukemia cells having relatively mature properties, such as chronic lymphocytic leukemia (CLL) and ATL cells. ' On the other hand, the antigen defined by the 2F3 antibody was hardly detectable on these leukemia cells of ALL origin. but was found to be remarkably expressed on leukemic cells ofthe ATL origin, or the cells infected with human T-cell leukemia virus (HTLV)-I in vitro, such as ATL-2, HUT 102, ED405 15, and HIL3 cells (Fig 5) . The expression of the 2F3defined antigen was most prominent in ED-405 I5 and HIL3 cells, both of which require supplementation of IL-2 in the culture medium for growth. When the ED405 15 cells were cultured without the addition of IL-2, the surface expression of the 2F3defined sialyl Le" antigen was decreased, and addition of IL-2 restored the antigen expression (Fig 5) .
Not all of the ATL-related cell lines were positive for the trates the expression pattern of the sialyl Lex antigen defined by the three antibodies in the leukemia cells of 10 patients with ATL. The 2F3 antibody showed much stronger staining than the other two classical antibodies in most cases. On average, 30.9% f 12.1% of the leukemic cells were positively stained with the 2F3 antibody, whereas only 7.4% f 5.7% and 8.4% ? 4.9% were positive for SNH-3 and FH-6, respectively (difference between 2F3 and SNH-3 or between 2F3 and FH-6 was significant at P < .OO 1 by the Student's t-test).
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It was noted that the leukemia cells from the ATL patients who had significant dermal infiltration of leukemic cells (cases KD, TM, KK, TS, YN, and MH) expressed the 2F3-defined sialyl Le" antigen more strongly (39.1% k 6.9% of the blasts were positive) than the blasts from the patients having a relatively acute clinical course without apparent skin involvement, such as cases SY, TF, IN, and EO (1 8.5% * 4.0% of the blasts were positive). The difference in the 2F3 positivity between these two populations was statistically significant at P -= .001 by the Student's t-test. On the other hand, expression of the classical sialyl Le" antigen was quite low in patients with skin infiltration (8.7% k 11.2% with SNH-3 and 5.5% f 6.6% with FH-6) as well as in acute ATL patients without skin involvement (7.5% * 2.5% with SNH-3 and 8.9% f 3.8% with FH-6), and the differences between the two populations were statistically not significant for either antibody.
Evidence that the antigen defined by the 2F3 antibody serves us the ligund for E-selectin. Several cultured ATLrelated cell lines that were positively stained with the 2F3 antibody were chosen and used to test the possible contribution of the antigen recognized by 2F3 in the cell adhesion to endothelial cells. ATL-2, ED-405 15, and HUT102 cells showed a clear E-selectin-dependent adhesion to IL-1 ,8-activated HUVECs (Fig 7) . The pretreatment of HUVECs with anti-E-selectin antibody significantly inhibited the adhesion of these cultured leukemia cells, and the addition of anti-E-selectin antibody to the mixture of anti-LFAI and anti-VCAM-1 antibodies in the pretreatment of cells (aL + aV + aE), clearly showed additional inhibition of cell adhesion when compared with the degree of inhibition with the mixture of anti-LFA1 and anti-VCAM-1 antibodies (aL + The adhesion of ATL-2, ED-40515, and HUT102 was clearly inhibited by the pretreatment of cells with the 2F3 antibody, whereas the pretreatment with antibodies SNH-3 or FH-6 was much less effective. This was consistent with the findings that these cells express the 2F3-defined antigen more strongly than the antigen recognized with SNH3 or FH6. Only a minute additive inhibitory effect was observed with SNH3 antibody in the case of ATL-2 and ED-405 15 cells.
In these experiments, we have included lymphocytic leukemia cell lines derived from CALL, which are reactive to SNH-3 but not reactive to 2F3. Some of these cell lines showed significant E-selectin-dependent adhesion to IL-1 &activated HUVECs, and the adhesion was significantly inhibited by the treatment with SNH-3 antibody but, naturally, not by the 2F3 treatment. The most typical pattern was observed with MOLT-15 cells. The results obtained CYV). with these CALL cell lines were essentially the same as our previously published result^.^' Either the classical or the 2F3-defined sialyl Le" antigen, when expressed, can mediate adhesion to E-selectin.
DISCUSSION
The results described in this report clearly indicated that human helper memory T cells express the sialyl Le"-like antigen, which is significantly different from the sialyl Le" antigen present on NK cells and activated T or B cells. A novel MoAb 2F3 defines the former antigen expressed on human helper memory T cells, and the classical anti-Le" antibodies such as SNH-3 and FH-6 detect the latter antigen. The sialyl Le" antigen defined by the 2F3 antibody is clearly distinguishable from the classical antigen, because 2F3 reacts only to helper memory T cells and not to NK cells, whereas the classical antibodies react to NK cells but not to the resting helper memory T cells in the very same peripheral blood samples.
It has been postulated that a certain subset of helper memory T cells can adhere to E-se1ectin,l2 although the sialyl Le" antigen is hardly detectable when usual anti-sialyl Le" antibodies were used for dete~tion.",~" We showed previously that peripheral resting T lymphocytes in healthy individuals do not express the sialyl Le" antigen using the SNH-3 and FH-6 antibodies,'~~ and Berg et a1 reported that sensitive flow cytometric analyses of peripheral blood cells showed only small but consistent T-cell subset staining with another anti-sialyl Le" antibody CSLEX-1.14 Recently, Munro et a1 reported that the antibody CSLEX-1 could weakly detect the antigen at the surface of some T cells.29 However, this CSLEX-1 -positive T-cell subset was not characterized further, and Munro et a1 stated that this antibody could also detect the antigen on 40% of NK cells. It seems that the CSLEX-1 antibody can broadly, although very weakly, detect both the classical and the 2F3-defined sialyl Le" antigen to some extent, and has a property between the classical antibodies and the novel antibody 2F3.
Berg et a1 showed that the HECA452 antibody could strongly stain a subset of helper memory T cells, in clear contrast to the CSLEX-1 antib~dy.'~ The reactivity profile of the 2F3 antibody against the lymphocyte subsets looks very similar to that of HECA452. However, the specificities of the 2F3 and HECA452 against carbohydrate antigen is quite different; 2F3 is reactive only to sialyl Le" and not reactive to sialyl Le", whereas HECA452 is reported to be reactive to both carbohydrate determinant^.^^ Among lymphocytic leukemia cells, the 2F3-defined sialyl Le" antigen was preferentially expressed on the ATL cells. This was in contrast to the distribution of the classical sialyl Le" antigen, which was frequently detected in ALL blasts, but only occasionally on ATL cells. antibodies; oL + UV + nE indicates a treatment with the mixture of anti-LFAl , anti-VCAM-1 and anti-E-selectin antibodies. Single asterisk, difference from the control value was significant at P < .05 by Student's t-test; **, at P < .01; ***, at P < .001.
frequency of 2F3-positive blasts; this probably depends on which subset of T cells was infected by HTLV-1 and underwent malignant transformation in these patients.
One of the characteristics of ATL is the high frequency of infiltration of the skin by the leukemia cells, which is rarely found in other acute lymphocytic leukemias. Recent clinical surveys indicate that as many as 38.9% of ATL patients exhibit skin i n v o l~e m e n t .~~*~~ In the present study, the patients having a high percentage of 2F3-positive blasts tended to exhibit significant skin infiltration of leukemia cells, whereas patients with low numbers of 2F3-positive blasts were characterized by an acute clinical course without skin involvement. The 2F3-positive ATL cells underwent a clear E-selectin-dependent adhesion to endothelial cells, and the 2F3-defined sialyl Le" antigen served as the major ligand in this adhesion. In this context, it is interesting to note that in earlier studies, the subset of helper memory T cells that adheres to E-selectin is reported to be preferentially recruited to the skin (skin-homing Our analysis indicated that the distinct type of sialyl Le" antigen that specifically reacts to the 2F3 antibody was present in oligosaccharides camed by the cellular glycoproteins, and this antigen is hardly recognized by the classical antisialyl Le" antibodies. It is postulated that various types of sialyl Le" antigens are present in either 0-linked or N-linked cellular glycoprotein^,^^.^^ but the exact carbohydrate structures of the determinants camed by glycoproteins mostly remain to be elucidated. At present, only the sialyl Le" determinants carried by type 2 core and type 3 core 0-glycoside are structurally c h a r a~t e r i z e d .~~,~~ The sialyl Le" antigenicity could be considerably affected by the linkage, length, or modification of the core structure that carries the antigenic determinant. What kind of molecular species of sialyl Le" antigen is recognized by the 2F3 antibody remains to be answered. Exact structural studies on the isolated oligosaccharides are now in progress in our laboratory.
